US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.54

-0.3850-2.03%

Pre-market: 18.47-0.0700-0.38%07:58 EDT

Volume:64.75K

Turnover:1.20M

Market Cap:107.55M

PE:- -

High:18.87

Open:18.87

Low:18.44

Close:18.93

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:2.51

T/O Rate:1.12%

Dividend:0.71

Dividend Rate:3.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine

CSPC Says FDA Clears US Clinical Trial for SYS 6037 Mpox mRNA Vaccine

CSPC Pharmaceutical - Sys6037 Mpox Mrna Vaccine Obtains FDA Clinical Trial Approval in U.S.

THOMSON REUTERS

Innovent Biologics Schedules Board Meeting to Review Interim Results

Innovent Biologics Slashes Prices on Weight-Loss Drug as Growth Concerns Mount

Akeso Doses First Patient in Phase II Trial of Ak146d1 ADC Plus Ivonescimab in Advanced Breast Cancer

Akeso Advances IO2.0 + Adc2.0 Strategy: First Patient Dosed in Phase Ii Study of Trop2/Nectin-4 Bispecific ADC (Ak146d1) Combined with Ivonescimab in Breast Cancer

THOMSON REUTERS

BOCOM International Lifts BEONE MEDICINES Price Target to HKD 276, Maintains Buy Rating

CRO Sector Surges as Wuxi Apptec Secures US Court Injunction, Suspending Defense Department Listing

Innovent Biologics Signs Exclusive Deal with Daiichi Sankyo to Commercialize Vanflyta in China

Goldman Sachs Competitor Adjusts BeOne Medicines Target Upward, Bullish Ratings Maintained

BEONE MEDICINES Confirms External CMO Supply for Baiyueda, All Processes On Schedule

BEONE MEDICINES: Approximately 95% of Pancreatic Cancer Cases Show KRAS Mutation, Around 20% Exhibit MTAP Deletion, Enabling Easy Identification of Overlapping Patient Groups

BEONE MEDICINES Reports BRUKINSA Captures Over Half of New CLL/SLL Patient Share

Beigene's GPC3x4-1BB Candidate Moves From Phase 1 to a Potential Pivotal Phase 2 Study in About 19 Months

BEONE MEDICINES Halts Initial KRAS Inhibitor Project but Remains Active in RAS Field

BEONE MEDICINES Plans to Unveil Preliminary CEA ADC Findings for Non-Small Cell Lung Cancer, Including Both Squamous and Non-Squamous Cases

Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust

CLSA Maintains Outperform Rating on BEONE MEDICINES, Raises Price Target to HK$321.70

Pharmaceutical Procurement Rules Advance: Market Shifts from Price War to Multi-Factor Competition

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/KURE/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.54,"timestamp":1788206400000,"preClose":18.925,"halted":0,"volume":64746,"hourTrading":{"tag":"盘前","latestPrice":18.47,"preClose":18.54,"latestTime":"07:58 EDT","volume":2000,"amount":36940,"timestamp":1788263922349,"change":-0.07,"changeRate":-0.003776,"amplitude":0},"delay":0,"changeRate":-0.020343461030383172,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Pre-Mkt","change":-0.385,"latestTime":"09-01 08:08:59 EDT","open":18.87,"high":18.87,"low":18.44,"amount":1197156.0003479999,"amplitude":0.022721,"askPrice":20.4,"askSize":100,"bidPrice":16.9,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.54,"sharesOutstanding":4750002,"nav":19,"aum":110211439.71,"dividendRate":0.038554,"bidAskSpread":0.005823,"preHourTrading":{"tag":"盘前","latestPrice":18.47,"preClose":18.54,"latestTime":"07:58 EDT","volume":2000,"amount":36940,"timestamp":1788263922349,"change":-0.07,"changeRate":-0.003776,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":18.54,"preClose":18.54,"latestTime":"19:30 EDT","volume":10,"amount":185.4,"timestamp":1788219002391,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.5088930826145392,"impliedVol":0.2767,"impliedVolPercentile":0.5777},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.5088930826145392,"shares":5800979,"dividePrice":0.7148,"high":18.87,"amplitude":0.022721,"preClose":18.925,"low":18.44,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":18.54,"eps":0,"divideRate":0.038554,"volume":64746,"delay":0,"ttmEps":0,"open":18.87,"prevYearClose":17.04,"prevWeekClose":18.925,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":18.6163,"twentyDayClose":17.0849,"sixtyDayClose":15.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182339913","title":"CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1182339913","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182339913?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:02","pubTimestamp":1786359759,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) announced that its investigational new drug, SYS 6037 injection (monkeypox mRNA vaccine), a Class 1 preventive biological product developed in collaboration with the Institute of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","PSYK","LU1152091754.HKD","LU1226287875.USD","IE00B031HY20.USD","KURE","LU1008478684.HKD","BK4505","LU1152091168.USD","BK4139","IE00BZ08YS42.EUR","LU1951186391.HKD","SG9999004220.SGD","IBBJ","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","IE0009354923.USD","LU1813983027.USD","LU0315179316.USD","LU1993786604.SGD","HK0000165453.HKD","BK1191","LU0880133367.SGD","RNA","IE00BZ08YR35.GBP","LU1226287792.SGD","LU1807302812.USD","IE00BZ08YT58.USD","MDTX","BMED","BK1515","LU1226288253.USD","LU0314109678.HKD","LU1226288170.HKD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","159646","IE00B5MMRT66.SGD","BK4585","01093","BK4588","LU0067412154.USD","IE0008368742.USD","IE00B543WZ88.USD","BK1521","IBBQ","LU0140636845.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658270980","title":"CSPC Says FDA Clears US Clinical Trial for SYS 6037 Mpox mRNA Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2658270980","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658270980?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:58","pubTimestamp":1786359481,"startTime":"0","endTime":"0","summary":"CSPC says FDA clears US clinical trial for SYS 6037 mpox mRNA vaccineCSPC’s SYS 6037 injection, an mRNA monkeypox vaccine co-developed with the Chinese Academy of Sciences’ Institute of Microbiology, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL4XF0Px:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00BZ08YS42.EUR","LU1008478684.HKD","LU1807302812.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU0072913022.USD","LU1328277881.USD","IE0008368742.USD","LU0314109678.HKD","BK1191","LU0880133367.SGD","HK0000165453.HKD","LU1226288170.HKD","LU1960683339.HKD","LU0501845795.SGD","LU1993786604.SGD","SG9999004220.SGD","LU1226287875.USD","LU0326950275.SGD","LU1226287792.SGD","01093","BK1521","LU0315179316.USD","IE00B031HY20.USD","LU1226288253.USD","IE00BZ08YR35.GBP","LU1152091168.USD","LU2039709279.SGD","LU1951186391.HKD","IE00BZ08YT58.USD","LU0067412154.USD","LU1813983027.USD","IE0008369823.USD","IE00B543WZ88.USD","LU1152091754.HKD","LU1226287529.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980216","title":"CSPC Pharmaceutical - Sys6037 Mpox Mrna Vaccine Obtains FDA Clinical Trial Approval in U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980216?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:57","pubTimestamp":1786359457,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B5MMRT66.SGD","BK1191","LU1152091168.USD","IE00B543WZ88.USD","LU0880133367.SGD","LU1152091754.HKD","LU1960683339.HKD","BK1515","LU1813983027.USD","LU0315179316.USD","IE0008369823.USD","LU1993786604.SGD","LU0067412154.USD","LU0140636845.USD","LU2039709279.SGD","IE00B031HY20.USD","SG9999004220.SGD","BK1521","HK0000165453.HKD","LU1008478684.HKD","LU1226288253.USD","LU1951186391.HKD","LU0072913022.USD","LU1226287792.SGD","IE0008368742.USD","LU1226287529.USD","LU0326950275.SGD","KURE","IE00BZ08YS42.EUR","LU0501845795.SGD","LU0314109678.HKD","LU1226287875.USD","LU1807302812.USD","LU1328277881.USD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","01093","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658475981","title":"Innovent Biologics Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658475981","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658475981?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:05","pubTimestamp":1786352720,"startTime":"0","endTime":"0","summary":"Innovent Biologics schedules board meeting to review interim resultsInnovent Biologics set a board meeting for Aug. 25, 2026 to review interim results for the six months ended June 30, 2026.Disclaimer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLbzWXSb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0244354667.USD","KURE","HK0000165453.HKD","01911","LU0455707207.USD","LU2097828631.EUR","LU0502904849.HKD","LU1188198961.HKD","BK1589","LU2097828557.USD","01801","LU2097828474.EUR","LU2097828805.USD","LU0463099449.HKD","BK1161","LU2328871848.SGD","LU2488822045.USD","LU2097828714.EUR","BK1583","LU1969619763.USD","LU2242644610.SGD","LU0326950275.SGD","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157613829","title":"Innovent Biologics Slashes Prices on Weight-Loss Drug as Growth Concerns Mount","url":"https://stock-news.laohu8.com/highlight/detail?id=1157613829","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157613829?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:10","pubTimestamp":1786349446,"startTime":"0","endTime":"0","summary":"Innovent Biologics (01801.HK) has delivered a surprisingly strong financial performance for the first half of 2026. On August 5, the company reported product sales revenue surging over 55%...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU2097828474.EUR","LU2097828805.USD","LU2328871848.SGD","LU1188198961.HKD","LU0455707207.USD","KURE","LU1969619763.USD","01801","LU2097828631.EUR","LU2242644610.SGD","LU2097828557.USD","LU0502904849.HKD","BK1161","HK0000165453.HKD","BK1583","LU0326950275.SGD","LU0463099449.HKD","LU2097828714.EUR","LU0244354667.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658602868","title":"Akeso Doses First Patient in Phase II Trial of Ak146d1 ADC Plus Ivonescimab in Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658602868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658602868?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:07","pubTimestamp":1786334823,"startTime":"0","endTime":"0","summary":"Akeso doses first patient in Phase II trial of AK146D1 ADC plus ivonescimab in advanced breast cancerAkeso dosed the first patient in a Phase II study of TROP2/Nectin-4 bispecific ADC AK146D1 combined","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLc1w1yj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","09926","LU0348735423.USD","LU0561508036.HKD","IE00B543WZ88.USD","LU0417516902.SGD","LU1720050803.USD","LU0417516571.SGD","LU0348783233.USD","LU0348827113.USD","LU0348784397.USD","LU1794554557.SGD","LU2488822045.USD","LU0417516738.SGD","IE00BPRC5H50.USD","LU0348766576.USD","BK1161","LU2399975544.HKD","LU0348825331.USD","IE00B5MMRT66.SGD","LU1961090484.USD","KURE","LU0348767384.USD","LU0540923850.HKD","LU2778985437.USD","LU0634319403.HKD","LU2476274308.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658460283","title":"Akeso Advances IO2.0 + Adc2.0 Strategy: First Patient Dosed in Phase Ii Study of Trop2/Nectin-4 Bispecific ADC (Ak146d1) Combined with Ivonescimab in Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658460283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658460283?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:06","pubTimestamp":1786334787,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA5SMJJP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B5MMRT66.SGD","LU0348766576.USD","KURE","LU1961090484.USD","BK1574","LU0561508036.HKD","LU2399975544.HKD","09926","LU1720050803.USD","LU2476274720.SGD","LU0540923850.HKD","LU2476274308.USD","LU2488822045.USD","BK1161","LU0348783233.USD","LU0348767384.USD","LU0348825331.USD","IE00BPRC5H50.USD","LU0417516902.SGD","LU0417516738.SGD","LU0634319403.HKD","LU0348735423.USD","LU2778985437.USD","LU0348784397.USD","LU0417516571.SGD","LU0348827113.USD","LU1794554557.SGD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175410099","title":"BOCOM International Lifts BEONE MEDICINES Price Target to HKD 276, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1175410099","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175410099?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:08","pubTimestamp":1786331293,"startTime":"0","endTime":"0","summary":"BOCOM International has released a research report raising its price target for BEONE MEDICINES (06160) from HKD 229.2 to HKD 276, while maintaining a \"Buy\" rating.In the second quarter, Zanubutinib...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","BK1161","LU1969619763.USD","BK4526","LU0828237510.HKD","LU2328871848.SGD","BK4139","BK1500","LU0588546209.SGD","LU0228659784.USD","LU1251922891.USD","KURE","LU1719994722.HKD","LU1770034418.SGD","BK1583","EWH","BK1588","BK4585","LU0307460666.USD","LU1303224171.USD","ONC","BK0239","BK4588","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158282156","title":"CRO Sector Surges as Wuxi Apptec Secures US Court Injunction, Suspending Defense Department Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1158282156","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158282156?lang=en_us&edition=fundamental","pubTime":"2026-08-10 10:02","pubTimestamp":1786327336,"startTime":"0","endTime":"0","summary":"CRO concept stocks are leading gains, with GENSCRIPT BIO (01548) up 6.44% to HK$24.46, WUXI APPTEC (02359) rising 5.36% to HK$202.8, WUXI BIO (02269) climbing 5.02% to HK$48.16, and PHARMARON (03759)...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU0039217434.USD","LU3063872942.SGD","LU2495084118.USD","LU0823426308.USD","LU0320764599.SGD","HK0000306685.HKD","LU0051755006.USD","IE00B5MMRT66.SGD","SG9999002463.SGD","02269","LU1719994722.HKD","KURE","LU0516422366.SGD","LU1770034418.SGD","LU0181495838.USD","LU0417516902.SGD","LU0348767384.USD","LU0856984785.SGD","LU1046422090.SGD","LU1997245177.USD","BK4588","LU0307460666.USD","HK0000306701.USD","LU0348825331.USD","LU0823426480.USD","VXUS","LU2328871848.SGD","LU0819121731.USD","LU1242518857.USD","LU0043850808.USD","HK0000320264.USD","LU1979443071.USD","BK1141","02359","BK4585","LU0456846285.SGD","LU0979878070.USD","LU0417516738.SGD","LU1880383366.USD","LU1808992512.USD","01548","LU0572944931.SGD","LU0588546209.SGD","LU0516422440.USD","LU0611395673.USD","LU0359201612.USD","LU0516423091.SGD","LU0456842615.SGD","LU0359202008.SGD","BK1589","LU2488822045.USD","LU2125910500.SGD","LU1688375341.USD","LU0700851271.USD","LU1997245094.SGD","BK0216","LU0516423174.USD","BK1521","603259","LU2045819591.USD","LU0140636845.USD","03759","LU0516422952.EUR","LU1720050803.USD","LU1251922891.USD","LU1303224171.USD","LU2039709279.SGD","LU0326950275.SGD","LU1934453819.USD","LU0052750758.USD","LU1997244956.HKD","LU2242644610.SGD","LU0456827905.SGD","IE00BPRC5H50.USD","LU1242518931.SGD","HK0000320223.HKD","BK1610","BK1583","BK1576","KCAI","LU0348735423.USD","LU0327786744.USD","IE00B0JY6N72.USD","LU1794554557.SGD","SG9999002562.SGD","LU0708995583.HKD","LU1969619763.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658605620","title":"Innovent Biologics Signs Exclusive Deal with Daiichi Sankyo to Commercialize Vanflyta in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2658605620","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658605620?lang=en_us&edition=fundamental","pubTime":"2026-08-10 08:00","pubTimestamp":1786320019,"startTime":"0","endTime":"0","summary":"Innovent Biologics signs exclusive deal with Daiichi Sankyo to commercialize Vanflyta in ChinaInnovent Biologics signed an exclusive deal with Daiichi Sankyo to commercialize Vanflyta (quizartinib) in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL9YX0hZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","01911","LU0244354667.USD","LU2097828805.USD","BK1589","LU2097828631.EUR","LU2242644610.SGD","LU2097828714.EUR","LU2097828557.USD","BK1147","KURE","LU2488822045.USD","LU0455707207.USD","LU0463099449.HKD","BK1583","LU0502904849.HKD","HK0000165453.HKD","LU1969619763.USD","LU2328871848.SGD","01801","LU1188198961.HKD","BK1161","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101035030","title":"Goldman Sachs Competitor Adjusts BeOne Medicines Target Upward, Bullish Ratings Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=1101035030","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101035030?lang=en_us&edition=fundamental","pubTime":"2026-08-09 09:50","pubTimestamp":1786240220,"startTime":"0","endTime":"0","summary":"A financial research report from a major investment bank indicates that, considering the strong growth of BeOne Medicines (stock code: 06160) drug sales and improved cost control, its net profit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0828237510.HKD","LU1303224171.USD","LU1770034418.SGD","BK1588","BK4526","ONC","BK1161","BK1583","688235","LU0228659784.USD","LU1969619763.USD","BK4585","LU0588546209.SGD","BK4139","LU1251922891.USD","BK1500","BK4588","LU0307460666.USD","BK0239","06160","LU1719994722.HKD","LU2328871848.SGD","EWH","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154033718","title":"BEONE MEDICINES Confirms External CMO Supply for Baiyueda, All Processes On Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=1154033718","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154033718?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:21","pubTimestamp":1786112491,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES stated during a research survey that its product, Baiyueda, is currently being supplied by an external Contract Manufacturing Organization (CMO). All related processes are proceeding...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4526","BK1583","LU0307460666.USD","BK1500","BK1588","BK4585","LU1770034418.SGD","KURE","BK4139","LU2328871848.SGD","LU1969619763.USD","BK4588","LU0588546209.SGD","688235","LU1303224171.USD","06160","BK0239","LU1719994722.HKD","LU1251922891.USD","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169077073","title":"BEONE MEDICINES: Approximately 95% of Pancreatic Cancer Cases Show KRAS Mutation, Around 20% Exhibit MTAP Deletion, Enabling Easy Identification of Overlapping Patient Groups","url":"https://stock-news.laohu8.com/highlight/detail?id=1169077073","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169077073?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:21","pubTimestamp":1786112482,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES stated during a research briefing that both MTAP deletions and KRAS mutations are high-frequency molecular events in human tumors, theoretically offering numerous opportunities for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","BK4139","BK1500","BK4526","ONC","KURE","LU2328871848.SGD","06160","LU1303224171.USD","LU0588546209.SGD","BK1588","BK1583","LU1719994722.HKD","BK1161","688235","LU1251922891.USD","LU1770034418.SGD","LU1969619763.USD","BK0239","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136694467","title":"BEONE MEDICINES Reports BRUKINSA Captures Over Half of New CLL/SLL Patient Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1136694467","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136694467?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:53","pubTimestamp":1786110785,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES disclosed during a recent investor briefing that, while different data sources may show slight variations in measuring new patient market share in the United States, BRUKINSA has...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","688235","BK1161","BK1500","BK0239","BK1583","06160","LU0307460666.USD","BK1588","BK4588","LU0588546209.SGD","BK4526","KURE","LU2328871848.SGD","LU1770034418.SGD","LU1969619763.USD","LU1303224171.USD","LU1251922891.USD","LU1719994722.HKD","BK4139","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120299531","title":"Beigene's GPC3x4-1BB Candidate Moves From Phase 1 to a Potential Pivotal Phase 2 Study in About 19 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=1120299531","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120299531?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:51","pubTimestamp":1786110707,"startTime":"0","endTime":"0","summary":"Beigene revealed during a recent investor call that its GPC3x4-1BB bispecific antibody transitioned from first-in-human studies to the initiation of a potential registrational Phase 2 trial in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","BK1500","KURE","688235","BK4526","LU2328871848.SGD","BK0239","BK4588","LU0307460666.USD","BK1583","BK1161","LU1770034418.SGD","LU1969619763.USD","06160","LU1303224171.USD","LU1719994722.HKD","BK4139","BK4585","LU1251922891.USD","LU0588546209.SGD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143385668","title":"BEONE MEDICINES Halts Initial KRAS Inhibitor Project but Remains Active in RAS Field","url":"https://stock-news.laohu8.com/highlight/detail?id=1143385668","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143385668?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:51","pubTimestamp":1786110683,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES has revealed that it has discontinued development of its original Pan-KRAS inhibitor known as BGB-53038. However, the company has confirmed that it is not withdrawing from the broader...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1251922891.USD","BK1588","KURE","LU1303224171.USD","BGB","BK4588","ONC","LU0588546209.SGD","BK4139","BK4585","LU0307460666.USD","LU2328871848.SGD","BK1161","06160","BK4526","LU1719994722.HKD","BK0239","BK1583","LU1770034418.SGD","LU1969619763.USD","688235","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114647524","title":"BEONE MEDICINES Plans to Unveil Preliminary CEA ADC Findings for Non-Small Cell Lung Cancer, Including Both Squamous and Non-Squamous Cases","url":"https://stock-news.laohu8.com/highlight/detail?id=1114647524","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114647524?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:50","pubTimestamp":1786110636,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160.HK) announced during a research briefing that it intends to publish early-stage data on its CEA-targeting antibody-drug conjugate (ADC) for non-small cell lung cancer (NSCLC),...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","BK1588","BK1161","LU1969619763.USD","BK4588","BK4080","BK4231","LU1770034418.SGD","ADC","ONC","LU0588546209.SGD","KURE","LU1303224171.USD","BK4585","BK4139","BK1500","BK0239","BK4526","LU2328871848.SGD","NETL","LU0307460666.USD","LU1251922891.USD","688235","LU1719994722.HKD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172057238","title":"Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust","url":"https://stock-news.laohu8.com/highlight/detail?id=1172057238","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172057238?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:04","pubTimestamp":1786086287,"startTime":"0","endTime":"0","summary":"Southern Hang Seng Biotech ETF has surged more than 5%, currently trading 5.4% higher at HK$3.628 with a turnover of HK$7.2374 million. This ETF tracks the Hang Seng Biotechnology Index, covering...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0348735423.USD","LU0456827905.SGD","LU0052750758.USD","01801","LU0348827113.USD","LU0708995583.HKD","LU0320764599.SGD","BK1576","LU0588546209.SGD","LU0181495838.USD","LU2476274308.USD","LU0043850808.USD","LU1688375341.USD","LU2097828557.USD","LU1242518931.SGD","LU0140636845.USD","SG9999002463.SGD","LU2045819591.USD","159992","LU2488822045.USD","LU1242518857.USD","IE00B0JY6N72.USD","BK1583","LU0051755006.USD","LU0572944931.SGD","LU2039709279.SGD","BK1500","LU3063872942.SGD","LU1770034418.SGD","LU2097828474.EUR","KURE","IE00B543WZ88.USD","BK4588","LU1961090484.USD","BK1587","BK4550","BK1521","LU0039217434.USD","LU0417516738.SGD","LU0348783233.USD","LU2476274720.SGD","BK1141","02359","MEDX","02269","IBBQ","LU0348767384.USD","SG9999002562.SGD","LU1719994722.HKD","LU1046422090.SGD","LU0417516902.SGD","LNGR","LU2778985437.USD","LU1794554557.SGD","LU0348784397.USD","09926","LU2125910500.SGD","FDN","LU0634319403.HKD","LU2328871848.SGD","LU1969619763.USD","LU0359201612.USD","LU0823426480.USD","LU2097828714.EUR","LU0455707207.USD","06978","LU0359202008.SGD","LU0502904849.HKD","LU0856984785.SGD","LU0516422952.EUR","LU0326950275.SGD","LU2097828631.EUR","LU1303224171.USD","LU0516423091.SGD","LU1720050803.USD","BK1574","BK1161","LU0516422440.USD","03174","LU0307460666.USD","LU1880383366.USD","BK1588","BK4585","LU2097828805.USD","LU0348825331.USD","LU0561508036.HKD","IE00BPRC5H50.USD","HK0000165453.HKD","LU0540923850.HKD","LU0823426308.USD","LU0456846285.SGD","LU2399975544.HKD","LU0417516571.SGD","BK1610","LU0979878070.USD","LU0516423174.USD","06160","IE00B5MMRT66.SGD","LU0516422366.SGD","LU0348766576.USD","LU0819121731.USD","LU2242644610.SGD","LU0327786744.USD","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175866516","title":"CLSA Maintains Outperform Rating on BEONE MEDICINES, Raises Price Target to HK$321.70","url":"https://stock-news.laohu8.com/highlight/detail?id=1175866516","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175866516?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:10","pubTimestamp":1786083040,"startTime":"0","endTime":"0","summary":"CLSA issued a research report raising the target price for BEONE MEDICINES (06160) from HK$291.9 to HK$321.7. The firm also increased the U.S. stock target for BEIGENE LTD SPON ADS EACH REPR 13 ORD...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","LU2328871848.SGD","KURE","BK0239","BK4588","688235","BK1161","BK4526","LU0307460666.USD","LU1770034418.SGD","LU1719994722.HKD","LU1303224171.USD","BK4139","BK4585","LU0588546209.SGD","LU1969619763.USD","ONC","EWH","LU1251922891.USD","BK1500","06160","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122643361","title":"Pharmaceutical Procurement Rules Advance: Market Shifts from Price War to Multi-Factor Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=1122643361","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122643361?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:54","pubTimestamp":1786082070,"startTime":"0","endTime":"0","summary":"Orient Securities Company Limited has released a research report analyzing the 12th round of national centralized drug procurement. The key shift is a move from \"low-price competition\" toward a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","BK1564","BK0028","BK0276","BK0188","BK0183","BK0012","03958","600958","KURE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}